Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Viking Therapeutics, Inc. | 4,475 | reported | 10 Mar 2026 | tx 2+184,475 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Mar 2026 | PURCHASE | Viking Therapeutics, Inc. | 4,475 | 33.50 USD | |
| 12 Jan 2026 | GRANT_AWARD | Viking Therapeutics, Inc. | 180,000 | 0.00 USD | deriv |